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Abstract
Trypanosoma brucei is the causative agent of African sleeping sickness. The polyamine biosynthetic pathway has the
distinction of being the target of the only clinically proven anti-trypanosomal drug with a known mechanism of action.
Polyamines are essential for cell growth, and their metabolism is extensively regulated. However, trypanosomatids appear
to lack the regulatory control mechanisms described in other eukaryotic cells. In T. brucei, S-adenosylmethionine
decarboxylase (AdoMetDC) and ornithine decarboxylase (ODC) are required for the synthesis of polyamines and also for the
unique redox-cofactor trypanothione. Further, trypanosomatid AdoMetDC is activated by heterodimer formation with a
catalytically dead homolog termed prozyme, found only in these species. To study polyamine regulation in T. brucei,w e
generated inducible AdoMetDC RNAi and prozyme conditional knockouts in the mammalian blood form stage. Depletion of
either protein led to a reduction in spermidine and trypanothione and to parasite death, demonstrating that prozyme
activation of AdoMetDC is essential. Under typical growth conditions, prozyme concentration is limiting in comparison to
AdoMetDC. However, both prozyme and ODC protein levels were significantly increased relative to stable transcript levels
by knockdown of AdoMetDC or its chemical inhibition. Changes in protein stability do not appear to account for the
increased steady-state protein levels, as both enzymes are stable in the presence of cycloheximide. These observations
suggest that prozyme and ODC are translationally regulated in response to perturbations in the pathway. In conclusion, we
describe the first evidence for regulation of polyamine biosynthesis in T. brucei and we demonstrate that the unique
regulatory subunit of AdoMetDC is a key component of this regulation. The data support ODC and AdoMetDC as the key
control points in the pathway and the likely rate-limiting steps in polyamine biosynthesis.
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Introduction
Human African trypanosomiasis is a neglected disease of sub-
Saharan Africa caused by the protozoan parasite Trypanosoma
brucei. Current estimates are that more than 50 million people are
at risk for infection [1]. Without treatment the disease is always
fatal and available drug therapy is limited by toxicity, difficult
dosing regimes, and emerging resistance [2]. Eflornithine (D,L-a-
difluoromethylornithine), a suicide inhibitor of ODC, is one of
only two drugs available for the treatment of the late-stage disease,
and its effectiveness has focused attention on the importance of the
polyamine biosynthetic pathway for parasite growth.
Polyamines are essential organic cations found in all species,
and the metabolic pathway has been extensively studied as a
potential target for the development of drugs to treat infectious
and proliferative diseases [3,4]. In most eukaryotes the diamine
putrescine is synthesized from L-ornithine by ODC, and it serves
as the precursor for the formation of the longer chain amine
spermidine (Figure 1). AdoMetDC catalyzes the formation of
decarboxylated S-adenosylmethionine required as the aminopro-
pyl group donor in the formation of the longer chain polyamines.
Unique to the trypanosomatids, spermidine is conjugated to
glutathione (GSH) to produce trypanothione, which is required in
cellular redox reactions and necessary for nucleotide synthesis [5].
Gene knockout studies in both T. brucei and Leishmania have been
reported for several of the polyamine and trypanothione
biosynthetic enzymes demonstrating that they are essential for
growth [6–13]. Genetic studies have not been reported for T. brucei
AdoMetDC, however several promising in vivo trials have shown
that AdoMetDC inhibitors cure T. brucei infections in mice,
providing chemical evidence that AdoMetDC is an important
drug target against this pathogen [14,15].
Polyamine homeostasis is essential for normal cellular function.
An excess of polyamines leads to hyperproliferation or tumori-
genesis, while polyamine deficiency is associated with cell growth
arrest leading to death [3,4]. As a consequence, polyamine pools in
eukaryotic cells are tightly regulated, and cells carefully orchestrate
a balance of polyamine biosynthesis, degradation and transport
into and out of the cell. In mammalian cells, ODC and
AdoMetDC are controlled by transcriptional, translational and
post-translational mechanisms [3,16,17]. Polyamine levels are also
regulated by back converting enzymes and polyamine transport.
ODC and AdoMetDC both have rapid intracellular turnover rates
in mammalian cells. Polyamines accelerate ODC degradation
above this basal rate through the action of a protein inhibitor,
antizyme [18]. T. brucei does not appear to encode the genes for
antizyme nor for the back conversion of polyamines, and it lacks
the general transcriptional control mechanisms found in other
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regulated in the parasite. Recently, we discovered that T. brucei
AdoMetDC is activated 1,200-fold (on kcat) by dimerization with a
catalytically dead paralog we termed prozyme [20]. This
mechanism for controlling AdoMetDC activity is unique to the
trypanosomatid parasites, and the finding raised the possibility that
regulation of prozyme expression could provide a parasite-specific
mechanism to control polyamine homeostasis in trypanosomatids.
In order to study the potential for AdoMetDC or prozyme to
function as regulators in polyamine biosynthesis we utilized RNA
interference (RNAi) or regulated knockout approaches in blood
form T. brucei parasites to deplete the cells of these proteins. Loss of
AdoMetDC or prozyme leads to decreases in spermidine and
trypanothione and to cell death. A large compensatory induction
in the expression levels of prozyme and ODC was observed after
either genetic depletion or chemical inhibition of AdoMetDC. Our
data support a translational control mechanism for the regulation
of these proteins and they provide the first demonstration that
polyamine biosynthesis is regulated in T. brucei. Thus AdoMetDC
and prozyme appear to play a central role in controlling
polyamine homeostasis in the parasite through a mechanism that
is not found in other eukaryotic cells. These data suggest that
prozyme arose as a mechanism to regulate the polyamine
metabolic flux in trypanosomes and they illustrate the multiplicity
of regulatory control mechanisms that have evolved in this
essential metabolic pathway.
Results
AdoMetDC is an essential enzyme in T. brucei
To test the effects of reduced AdoMetDC expression on blood
form T. brucei parasites, we generated a stable cell line with an
inducible AdoMetDC targeted RNAi. This line contains a
tetracycline (Tet) inducible stem-loop vector with 620 bp frag-
ments of AdoMetDC in opposite orientations integrated into the
rRNA gene locus (Figure S1). Addition of Tet leads to production
of a double stranded stem-loop RNA targeting AdoMetDC
mRNA for degradation. Uninduced AdoMetDC RNAi cells grew
at the same rate as the parent 90-13 cells (data not shown).
Induction of the AdoMetDC RNAi (+Tet) leads to a reduction in
AdoMetDC protein that was maintained until the cells die
(Figure 2A and 2B). Cell growth arrest was observed within
4 days of induction, followed by cell death (day 11). Exogenous
spermidine (0.1 mM) restored normal growth to the induced cells,
demonstrating that the AdoMetDC RNAi specifically targeted
spermidine biosynthesis (Figure 2A).
AdoMetDC depletion reduces polyamine and
trypanothione pools
The polyamine and trypanothione metabolite profile was
assessed in the AdoMetDC RNAi cells. Intracellular putrescine
levels increased 6–7-fold within 2 days of RNAi induction, while
spermidine, glutathionyl-spermidine (GSH-Spd) and trypa-
nothione levels gradually declined, with a near complete depletion
of GSH-Spd and trypanothione being observed by day 6 after
induction (Figure 2C and 2D, and Table S1). The loss of these
Figure 1. The polyamine biosynthetic pathway in T. brucei. AdoMetDC, S-adenosylmethionine decarboxylase; ODC, ornithine decarboxylase;
SpdSyn, spermidine synthase; cGCS, c-glutamylcysteine synthetase; TrypSyn, trypanothione synthetase; TrypRed, trypanothione reductase; Spd,
spermidine; Put, putrescine; AdoMet, S-adenosylmethionine; cGC, c-glutamylcysteine; GSH, glutathione; GSH-Spd, glutathionyl spermidine; TS2,
oxidized trypanothione; T(SH)2, reduced trypanothione.
doi:10.1371/journal.ppat.1000183.g001
Author Summary
Human African trypanosomiasis (HAT) is an important
vector-borne pathogen. The World Health Organization
estimates that more than 50 million people are at risk for
the disease, which occurs focally, in remote regions, and
periodically reaches epidemic levels. Untreated HAT is
always fatal, and the available drugs compromise toxicity
and emerging resistance. The only safe treatment for late-
stage disease is an inhibitor of an essential metabolic
pathway that is involved in the synthesis of small organic
cations termed polyamines. In this paper, we use genetic
approaches to demonstrate how the parasite regulates
this essential metabolic pathway. By modulating the
protein levels of a trypanosome-specific activator of
polyamine biosynthesis, the parasite has developed a
mechanism to regulate pathway output. We also demon-
strate that this pathway activator is essential to parasite
growth. Our data strengthen the genetic and chemical
validation of a key enzyme in this pathway as a drug target
in the parasite, and they provide new insight into parasite-
specific approaches that could be used to design novel
drugs against this deadly disease.
Regulation of Polyamines in Trypanosoma brucei
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Spermidine was decreased to just below 40% of uninduced
controls. Addition of exogenous spermidine to the medium
restored the GSH-Spd and trypanothione pools to 70–80% of
wild-type levels, while spermidine levels were returned to 60–70%
of controls. Under these conditions the cells grow normally. Cell
growth could be rescued by spermidine up to four days post-
induction, however by day six it was no longer effective (Figure
S2). This correlates to the time frame when complete depletion of
GSH-Spd/trypanothione is observed (Figure 2D) suggesting that
the cells undergo an irreversible event in the absence of reduced
GSH-Spd/trypanothione that commits them to death.
AdoMetDC depletion leads to the induction of prozyme
and ODC expression
To determine if AdoMetDC knockdown is coupled to changes
in the expression of other enzymes in the pathway, Western
analysis of prozyme, ODC, spermidine synthase (SpdSyn),
trypanothione synthase (TrypSyn) and trypanothione reductase
(TrypRed) was undertaken over the time course of the AdoMetDC
RNAi induction (Figure 2B). Prozyme protein levels were
markedly increased relative to the tubulin control by day 2 after
RNAi induction (Figure 2B). ODC was also consistently higher
upon depletion of AdoMetDC. This induction of the prozyme and
ODC proteins was observed in the presence and absence of
exogenous spermidine, demonstrating that the increased expres-
sion is not a result of cell growth effects. No significant effects on
the expression of the other pathway enzymes were observed.
Control experiments on 90-13 cells (6Tet) demonstrated that Tet
had no affect on the expression patterns of any of the tested
enzymes (Figure S3).
Prozyme is essential for growth of T. brucei
The importance of prozyme to growth of blood form T. brucei
was evaluated by the generation of a prozyme conditional knock
out (cKO) cell line. T. brucei is a diploid organism, thus to generate
Figure 2. The effects of AdoMetDC knockdown by RNAi on blood form T. brucei. (A) Cell growth curves. Log cell number versus days in
culture: triangle, uninduced control cells (AdoMetDC RNAi line without Tet); circle, induced cells (AdoMetDC RNAi line +1 mg/ml Tet); square, induced
cells plus spermidine (AdoMet RNAi line +1 mg/ml Tet, +0.1 mM Spd). Complete cell death was observed by day 11. Data is displayed in Log units
(where log (n) is represented by (n) on the y-axis). (B) Western blot analysis of polyamine/trypanothione biosynthetic enzymes (20 mg total protein).
Time corresponds to days post Tet induction of AdoMetDC RNAi, in the absence (left) and presence (right) of spermidine (0.1 mM). The control lane
(day 0) on the right panel was cultured in the presence of spermidine for six days prior to the addition of Tet. Prozyme is denoted by (*). (C) Analysis
of intracellular polyamine levels. (D) Analysis of intracellular thiol levels. The polyamines Put and Spd, and thiols, GSH, GSH-Spd, and T(SH)2 are shown
as a percentage of control values (Uninduced AdoMetDC RNAi line). The concentration data (nmoles/10
8 cells) for all time points and conditions are
provided in Table S1. Errors represent the standard error of the mean (n=3).
doi:10.1371/journal.ppat.1000183.g002
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polymerase and a G418 selectable marker, a Tet responsive
FLAG-tagged prozyme gene was integrated into the rRNA locus,
and finally the second prozyme allele was replaced by the Tet
repressor gene and a hygromycin selectable marker (Figure S1B).
Southern blotting confirmed the correct integration of the three
vectors (Figure S4). Prozyme cKO cells maintained in the presence
of Tet expressed the FLAG-tagged prozyme protein and had
similar growth rates to wild-type 427 cells (data not shown). Upon
removal of Tet, prozyme expression was reduced to undetectable
levels, leading to a rapid arrest of cell growth (day 2) followed by
cell death (day 6) (Figure 3A and 3B). Unlike the AdoMetDC
RNAi line, the addition of exogenous spermidine did not restore
cell growth. These data demonstrate that prozyme is essential for
the growth of blood form parasites, and they show that the low
activity of homodimeric AdoMetDC (,0.1% of AdoMetDC/
prozyme heterodimer activity) is insufficient to promote cell
growth. In addition the data confirm that the AdoMetDC/
prozyme heterodimer is the functional configuration of Ado-
MetDC in the cell.
Prozyme knockout leads to depletion of spermidine and
trypanothione
Loss of prozyme in cKO cells resulted in a large increase in
putrescine levels (about 10 fold increase), similar to what is seen
during AdoMetDC knockdown (Figure 3C and Table S2).
However, in these cells a more substantial reduction in spermidine
was observed and it was decreased to 5–7% of the levels detected
in the uninduced control cells. Similarly to the AdoMetDC RNAi
line, GSH-Spd and trypanothione declined to 5–7% of control
levels, while GSH pools were 30–50% of controls (Figure 3D). The
decline in the GSH pools suggests that part of this pool has been
oxidized as the cell attempts to compensate for the loss of reduced
Figure 3. The effects of Prozyme knockout on blood form T. brucei. (A) Cell growth curves. Log cell number versus days in culture. Triangle,
Flag-tagged prozyme Expressed (prozyme cKO line +1 mg/ml Tet); circle, prozyme Not expressed (prozyme cKO line no Tet); square, prozyme Not
expressed plus spermidine (prozyme cKO line no Tet, +0.1 mM Spd). Complete cell death was observed by day 6. Data is displayed in Log units. (B)
Western blot analysis of polyamine/trypanothione biosynthetic enzymes (20 mg total protein). Time corresponds to days in the absence of Tet, with
(left) or without (right) spermidine (0.1 mM). Flag-antibody detects Flag-tagged prozyme. (C) Analysis of intracellular polyamine levels. (D) Analysis of
intracellular thiol levels. The polyamines Put and Spd, and thiols, GSH, GSH-Spd, and T(SH)2 are shown as a percentage of control values (prozyme
cKO +Tet). The concentration data (nmoles/10
8 cells) are provided in Table S2. Errors represent the standard error of the mean (n=3).
doi:10.1371/journal.ppat.1000183.g003
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intracellular spermidine pools (up to 26% of control cell levels);
however, the GSH-Spd and trypanothione levels remained below
10%, explaining why the cell growth defect was not rescued.
Prozyme depletion leads to increased expression of ODC
To look for potential regulation of the polyamine biosynthetic
enzymes,we monitored the proteinlevels of otherpathway enzymes
by Western blotting in prozyme cKO cells (Figure 3B). Changes in
the protein levels of AdoMetDC, TrypSyn, SpdSyn, or TrypRed
were not observed in response to the shut down of prozyme
expression. However, ODC protein levels increased similarly to that
observed upon knockdown of AdoMetDC expression.
Prozyme is present in limiting concentration under
normal growth conditions
In order to determine if AdoMetDC and prozyme are present at
similar concentrations, or if one is in excess over the other we
measured AdoMetDC activity in cell lysates in the presence and
absence of exogenous recombinant prozyme (1 mM). AdoMetDC
activity in 427 parental cells was compared to the AdoMetDC
RNAi cells (6Tet) and to the prozyme cKO cells (6Tet) (Figure 4).
In the control cells (427 cells or AdoMetDC RNAi (2Tet)) the
addition of prozyme stimulates AdoMetDC by 5–8-fold, demon-
strating that under normal growth conditions prozyme is present
in limiting concentration in comparison to AdoMetDC. Knock-
down of AdoMetDC (RNAi +Tet) or of prozyme (cKO–Tet),
reduced AdoMetDC activity by 60% and 80%, respectively,
showing that while neither knockdown approach completely
eliminates the protein targets, the prozyme cKO is more efficient
at depleting AdoMetDC activity than the induction of AdoMetDC
RNAi. The addition of exogenous prozyme has a minimal effect
on the activity of the Tet induced AdoMetDC RNAi cells,
however activity is increased significantly for the prozyme cKO
cells (2Tet), showing that added prozyme can restore activity to
the lysate that lacks endogenous prozyme. These data demonstrate
that prozyme is present in limiting concentration under typical
growth conditions of the wild-type 427 cells, positioning the cell to
increase pathway flux by upregulating prozyme levels.
Quantitative analysis of Prozyme and ODC protein and
mRNA levels: Expression levels of protein but not mRNA
are upregulated by AdoMetDC knockdown
We undertook quantitative analysis of the effects on protein and
mRNA levels to gain mechanistic insight into the observed
induction of prozyme and ODC upon knockdown of AdoMetDC
or prozyme. Protein amounts were determined by quantitative
Western blotting with fluorescent secondary antibodies, and
Northern blots were developed by phosphorimaging; the density
of these signals was then quantitated using imaging software and the
effects determined relative to tubulin controls (Figure 5A and 5B
and Table S3 show a representative data set). AdoMetDC protein
and mRNA levels were reduced by 70–80% compared to controls
by induction of RNAi, consistent with the activity data. In response,
as observed in Figures 2 and 3, both prozyme and ODC protein
levels are induced. The induction of prozyme is consistently more
robust and occursearlierinthe time course thanfor ODC. Prozyme
protein increased by an average of 25-fold (range 12–40-fold, n=3),
while ODC increased 7-fold (range 5–10-fold, n=3) (day 4 +Tet;
Figure5CandTableS4).Inthepresenceofspermidine,knockdown
of AdoMetDC also led to induction of prozyme and ODC protein,
with observed average increases of 10 and 5-fold, respectively (day 4
+Tet, +Spd). Finally, quantitative analysis of the prozyme cKO line
showed that the loss of prozyme expression also led to induction of
ODC, with ODC protein levels increasing by 4- and 5-fold (day 2
and 3 without Tet, respectively) (Figure S5 and Table S4).
In order to confirm that the magnitude of the ODC protein
induction was accurately measured by our quantitative analysis we
also performed activity assays on the same sample set. ODC
activity increased between 8–13-fold (days 4 and 6 no Spd) and by
4–5 fold (days 4 and 6 plus Spd) after induction of AdoMetDC
RNAi, and by 9-fold after the expression of prozyme was turned
off in the cKO line (day 3 2Tet). These data show that the
observed induction of ODC protein correlates with a similar
increase in ODC activity.
For both prozyme and ODC the mRNA levels remained
relatively constant, and were within 2-fold of the levels detected for
control samples (Figure 5B and Table S3), thus the observed
changes in protein expression arise predominately from increased
protein levels. These data suggest that the expression of prozyme
and ODC is controlled either at the level of translation, or through
a post-translational mechanism. In contrast, the expression levels
of the remaining pathway enzymes are not regulated under the
experimental conditions and the protein and mRNA levels remain
within 2-fold of the uninduced controls (Figure 5 and Table S3).
Prozyme and ODC protein levels are induced by the
AdoMetDC inhibitor MDL 73811
In order to determine if the induction of prozyme and ODC in
the AdoMetDC RNAi line was due to the loss of AdoMetDC
protein or AdoMetDC activity, we monitored protein levels by
Western blotting in the presence of MDL 73811 (59-([(Z)-4-amino-
2-butenyl]methylamino)-59-deoxyadenosine), a suicide inhibitor of
AdoMetDC [15]. The growth effects of MDL 73811 were first
determined for blood form 427 parasites and for the AdoMetDC
RNAi line in the absence of Tet (EC50=25–50 nM). Cells were
then cultured in MDL 73811 concentrations near the EC50 (25
and 75 nM MDL 73811) and AdoMetDC, prozyme, ODC,
TrypSyn and TrypRed were followed by Western over a 24–48 h
time course (Figures 5, 6A, and 6B, and Table S4). The
Figure 4. Measurement of AdoMetDC in cell lysates in the
presence of excess exogenous prozyme. AdoMetDC activity was
measured in the absence (orange) and presence (green) of added
recombinant prozyme (1 mM) for 427 parental cells, AdoMetDC RNAi
cells (2Tet control and +Tet induction of RNAi for 4 days), and prozyme
cKO cells (expressing prozyme (+Tet), and not expressing prozyme
(2Tet) collected day 2 after Tet removal). Errors represent the standard
error of the mean (n=3).
doi:10.1371/journal.ppat.1000183.g004
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followed as a control (6Tet). Knockdown of AdoMetDC by RNAi
led to induction of prozyme and ODC protein within 12 h of Tet
addition. Prozyme and ODC protein levels were induced by MDL
73811 as early as 3 h after its addition to the culture, with protein
levels increasing by 10 and 6-fold, respectively after 24 h (Figures 5
and 6). AdoMetDC levels declined by 40% in the presence of
MDL 73811, while the levels of TrypSyn, SpdSyn and TrpRed
were unchanged. The mRNA levels of the pathway enzymes were
within 2-fold of the levels for the control cells after MDL 73811
treatment. These data demonstrate that prozyme and ODC
protein levels are rapidly upregulated by either genetic knockdown
of AdoMetDC or by its chemical inhibition.
Prozyme and ODC are stable in the presence of
cycloheximide
The protein synthesis inhibitor cycloheximide was added to the
cells to determine if changes in protein turnover rates account for
the induction of prozyme and ODC protein upon loss of
AdoMetDC activity. Cycloheximide prevented the induction of
both prozyme and ODC by MDL 73811, demonstrating that new
protein synthesis is required to observe the upregulation of both
proteins. AdoMetDC, prozyme and ODC protein levels in the
control cells were stable over the course of the 6 h experiment
(Figure 6C and 6D), suggesting that changes in protein turnover
rates do not account for the rapid induction of protein levels
observed either in the presence of MDL 73811 or during genetic
depletion of AdoMetDC. Therefore, changes in translational
efficiency are implicated as the mechanism for induction of
prozyme and ODC.
Discussion
Polyamines are essential growth modulators that are highly
regulated in eukaryotic cells. The studies herein demonstrate that
AdoMetDC and prozyme are both essential for the growth of
blood form T. brucei, and they provide the first evidence that the
Figure 5. Comparison of prozyme and ODC protein and mRNA levels upon AdoMetDC knockdown. The AdoMetDC RNAi line was
induced with Tet, and samples were collected over the time range and conditions described in Figure 2. A representative data set is displayed.
Samples were visualized on a Typhoon 8610 scanner and quantitated as described in Materials and Methods. (A) Western analysis. (B) Northern blot
analysis. (C) Quantitation of relative ODC and prozyme protein (solid symbols) and mRNA (open symbols) levels. Protein and mRNA levels were
normalized to tubulin controls and are displayed as a fold change relative to uninduced control cells (2Tet). AdoMetDC, green triangles; prozyme,
purple squares; and ODC, orange circles. The plotted data can be found in Tables S3 and S4. Errors represent the standard error of the mean.
doi:10.1371/journal.ppat.1000183.g005
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data implicate both prozyme and trypanothione in regulation of
polyamine homeostasis in T. brucei, suggesting that the evolution of
these trypanosomatid-specific factors may have been linked to the
need to acquire regulatory control mechanisms to modulate the
growth effects of polyamines on the cell.
Few targets in the T. brucei parasite are validated both genetically
and chemically, and the data presented here contribute to a
compelling case that AdoMetDC is a promising drug target for the
development of new treatments for African sleeping sickness. We
have shown that prozyme is an essential activator of AdoMetDC
activity and that the low activity of the AdoMetDC homodimer on
its own is insufficient to maintain cell growth. Thus inhibitors that
block heterodimerization, or lock the AdoMetDC structure into an
inactive confirmation would provide a parasite-specific mechanism
to inhibit this essential enzyme. Successful strategies for these
approaches have recently been described, e.g. for Abl kinase [21]
and the Bcl-X/BAK interaction [22]. The AdoMetDC knockdown
by RNAi led to an 70–80% reduction in AdoMetDC protein that
was sufficient to cause cell death, suggesting that a small molecule
inhibitor of AdoMetDC would not need to fully inhibit AdoMetDC
to be effective. A postulated mechanism for selective toxicity of
ODC inhibitors is differential rates of intracellular protein turnover
between the rapidly degraded mammalian ODC and the stable
trypanosome enzyme [23]. We find that T. brucei AdoMetDC is also
a stable protein, while like ODC mammalian AdoMetDC has a
short intracellular half-life [24]. Thus differential enzyme turnover
may also contribute to selective toxicity of AdoMetDC inhibitors in
T. brucei. Finally, the AdoMetDC suicide inhibitor MDL 73811 is a
potent anti-trypanosomal agent [14,15]. Our finding that prozyme
levels are induced by MDL 73811 provides strong evidence
supporting AdoMetDC inhibition as the mechanism of action of
MDL 73811 in T. brucei, strengthening the chemical validation of
the target.
It appears that T. brucei regulates the polyamine pathway flux to
maintain spermidine homeostasis while depleting the conjugated
Figure 6. The effects of chemical inhibition of AdoMetDC on the expression of polyamine biosynthetic enzymes. (A) Comparison of
AdoMetDC genetic knockdown with AdoMetDC inhibition by MDL 73811. AdoMetDC RNAi cells were split into fresh media and induced with Tet, or
treated with 25 or 75 nM MDL73811. Cells were collected over a 24–48 h time course and analyzed by Western blot. (B) Analysis of protein and mRNA
levels in 427 cells treated with MDL 73811 for 24 h. Protein (solid symbols) and mRNA (open symbols) were normalized to tubulin controls and then
displayed as a fold change relative to untreated cells. The gel used for quantitation is displayed in Figure 5. AdoMetDC, green triangles; prozyme,
purple squares; and ODC, orange circles. (C) The effect of cycloheximide treatment on protein expression. Cycloheximide (CHX) (50 mg/ml) and/or
MDL 73811 (MDL) (75 nM) were added to the culture and cells were collected for Western analysis after 3, 4.5, and 6 hrs of drug treatment. Control
cells underwent identical procedures but were not treated with either CHX or MDL73811. (D) Quantitation of protein levels of AdoMetDC, prozyme,
and ODC during treatment with cycloheximide. Values are shown as the ratio to tubulin controls, normalized to untreated cells at time zero.
AdoMetDC, green; prozyme, purple; and ODC, orange. Errors represent the standard error of the mean (n=2).
doi:10.1371/journal.ppat.1000183.g006
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control levels after induction of AdoMetDC RNAi, and they are
only fully depleted in the prozyme cKO, which generated a more
complete knockdown of AdoMetDC activity. Addition of exoge-
nous spermidine to the prozyme cKO line partially restored the
spermidine pools, but not the GSH-Spd and trypanothione pools,
suggesting that the cell does not build up the GSH-Spd and
trypanothione pools until spermidine levels reach an appropriate
steady-state set point. In support, eflornithine treatment has been
reported to cause only a partial depletion of spermidine [25,26].
These data further provide evidence that the loss of trypanothione
pools is a central factor in cell death for both the AdoMetDC
knockdown cells and during eflornithine treatment. TrypSyn
contains both a synthetic domain catalyzing the formation of
GSH-Spd and trypanothione, as well as a catabolic domain that is
able to degrade both conjugates back to free spermidine and GSH
[27]. The function of the catabolic domain has not been
demonstrated in vivo, however our data supports the idea that
trypanothione serves as a cellular reservoir for spermidine and that
its catabolism contributes to spermidine homeostasis in the cell.
This mechanism would provide an analogous situation to that
observed in mammalian cells where catabolism of spermine and
spermidine play crucial roles in regulating pathway flux [28].
The finding that spermidine was able to rescue the cell growth
defect caused by the AdoMetDC RNAi knockdown, but not the
prozyme cKO is not entirely understood. Underlying this
observation is the finding that exogenous spermidine restored
the spermidine and trypanothione pools to the AdoMetDC RNAi
cells but not the prozyme cKO cells. We did not observe any
difference in spermidine uptake between these lines (unpublished
observation) but did find as has been previously published that
spermidine is poorly taken up by T. brucei blood form parasites
[10]. The prozyme cKO led to a 30% greater reduction in
AdoMetDC activity than the AdoMetDC RNAi knockdown, and
this correlates with a more rapid and complete depletion of
spermidine and trypanothione and to more rapid cell growth
arrest. This data, in combination with the spermidine pool
analysis, suggests that spermidine incorporation is only sufficient to
restore GSH-Spd and trypanothione pools after AdoMetDC
RNAi, where more residual AdoMetDC remains to help bolster
the spermidine pools than is observed in the prozyme cKO
(Figure 4). A further caveat is the observation that spermidine is
able to rescue the AdoMetDC RNAi lines when added up to day 4
after Tet induction, while it can not rescue these lines if added as
late as day 6. This corresponds to the point in the growth curve
where the GSH-Spd and trypanothione pools have become
completely depleted, suggesting that the cells have undergone an
irreversible event in the absence of these pools that commits them
to death. For the prozyme cKO line, even at the earliest time point
measured (day 2), the GSH-Spd and trypanothione pools were
completely depleted, so it may be that the prozyme cKO cells
undergo the irreversible transition too quickly for spermidine
rescue to be effective.
T. brucei responds to loss of spermidine by upregulating two key
proteins required for spermidine production, ODC and prozyme.
Either the genetic knockdown of AdoMetDC or its chemical
inhibition by MDL 73811 led to a rapid and robust increase in
prozyme and ODC protein levels. Spermidine rescue of the
AdoMetDC RNAi line fully restored normal cell growth, yet the
induction of the prozyme and ODC proteins still occurred,
providing strong evidence that the induction was not linked to
non-specific cell growth effects. The fact that either genetic or
chemical loss of AdoMetDC activity leads to increased protein
levels of ODC and prozyme provides cross-validation for the
observation and demonstrates that the effects do not result from
some peculiarity of the genetic system. In wild-type cells prozyme
is present in limiting concentration in comparison to AdoMetDC.
Thus prozyme is positioned to function not only as an essential
activator of AdoMetDC, but by dynamically altering its levels the
cell has a mechanism to modulate spermidine production
depending on its metabolic state. The pyruvoyl-dependant
mechanism of AdoMet decarboxylation is inherently prone to
enzyme inactivation through abortive deamination, which occurs
at a significant frequency during the catalytic cycle [29].
Mammalian cells may utilize rapid turnover of AdoMetDC as a
mechanism to replace the damaged enzyme. Perhaps in the
trypanosomatids, where AdoMetDC is a stable protein, the ability
to rapidly upregulate the allosteric activator, prozyme, provides an
alternative mechanism to evade substrate-mediated inactivation of
AdoMetDC by allowing the AdoMetDC pools to remain inactive
until needed.
The expression of prozyme and ODC both appear to be under
translational control. First the protein levels of prozyme and ODC
increased substantially upon loss of AdoMetDC activity, while the
mRNA levels were not significantly affected. Thus the increased
protein accumulation results from either increased translational or
from post-translational changes in protein stability. Secondly,
prozyme, ODC and AdoMetDC were stable over the 6 h
incubation with cycloheximide demonstrating that changes in
protein turnover are unlikely to contribute to the increase in
steady-state protein levels. The control of gene expression in T.
brucei is unusual in comparison to other eukaryotic cells. In T. brucei
mRNAs are transcribed as polycistronic units and polymerase II
gene transcription is not regulated at the level of transcription
initiation [19]. Instead gene expression is regulated post-
transcriptionally through changes in message stability, protein
stability or through translational regulation. Examples of transla-
tional control in T. brucei are limited but include developmental
regulation of procyclin [30–32], cytochrome oxidase isoforms [33]
and of Nrk protein kinase [34]. Cytochrome c has been shown to
be regulated post-translationally by differential protein stability
[35]. The finding that polyamine biosynthesis in T. brucei is likely
to be translationally regulated shows that translational control in
T. brucei is not limited to developmental regulation but also
functions as a mechanism to regulate house-keeping enzymes
involved in primary metabolism during the cell cycle.
An open question is what triggers the de-repression of ODC and
prozyme protein expression in response to loss of AdoMetDC.
Protein levels are increased by either knockdown or inhibition of
AdoMetDC, thus loss of AdoMetDC activity appears to be the
common element in triggering the response. The precedent in
other eukaryotic cells is that changes in spermidine levels affect the
ribosome and thus influence translation. Expression of the ODC
inhibitor antizyme is controlled by ribosomal frame-shifting which
is stimulated by spermidine, or by putrescine at higher
concentrations [36,37]. Translation of AdoMetDC in mammalian
cells and plants is regulated by a ribosome-stalling peptide that
traps the ribosome so that AdoMetDC mRNA is translated
efficiently only at low spermidine concentration [38,39]. In T.
brucei there are no apparent upstream open reading frames in
prozyme or ODC, and changes in spermidine concentration
appear unlikely to trigger the observed translational changes, since
protein levels were induced even in the spermidine rescued
AdoMetDC RNAi knockdown cells. The elevated putrescine levels
(6–10-fold) observed in the metabolite profiles for cells that express
higher levels of prozyme and ODC is a potentially significant
observation, but it seems an unlikely trigger for an increase in
ODC expression. Human and malaria dihydrofolate reductase
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the message [40,41]. For the human enzyme binding to mRNA is
prevented by the enzyme inhibitor methotrexate. This suggests an
intriguing hypothesis that is consistent with our data. AdoMetDC
may bind to both the prozyme and ODC mRNA and thereby
inhibit their translation.
The regulated expression of prozyme is a unique mechanism for
controlling polyamine pathway flux in T. brucei not found in other
eukaryotic cells. However, despite differences in the protein
components the metabolic control points of the pathway in T.
brucei are similar to those found in mammalian cells, with
regulation being focused on control of ODC and AdoMetDC.
Thus the data suggests that similarly to mammalian cells, ODC
and AdoMetDC catalyze the rate-limiting steps in polyamine
biosynthesis in T. brucei. While the mechanisms differ, both utilize
translational regulation of regulatory proteins to control the
pathway flux. Mammalian cells translationally regulate an ODC
inhibitor protein, antizyme, while T. brucei regulates an Ado-
MetDC activator protein, prozyme. Thus T. brucei has evolved a
unique but parallel regulatory mechanism to control polyamine
metabolism to that found in mammalian cells. These data provide
evidence for convergent evolution of translational control
mechanisms centered on regulatory binding proteins in the
polyamine metabolic pathway.
Materials and Methods
Trypanosome culture
Bloodstream form trypanosomes (90-13 or 427) were cultured in
HMI-9 media supplemented with 10% serum at 37uC, 5% CO2 as
described [42]. Chicken serum was used in place of fetal bovine
serum, allowing for the addition of spermidine (0.1 mM) without
encountering polyamine oxidase-driven toxicity [7]. Cells were
grown with the appropriate antibiotics (G418, 2.5 mg/ml;
hygromycin 5 mg/ml; phleomycin 2.5 mg/ml, blasticidin 2.5 mg/
ml) and were split every 24–48 hours to maintain cultures in log
phase (10
5 to 10
6 cells/ml). Cell densities were determined by
counting on a hemocytometer (Brightline, Fisher). Growth curves
are represented as total cell number (product of cell density and
total dilution) and all data were collected in biological triplicate.
To determine the effects of MDL 73811, AdoMetDC RNAi or
427 cells were cultured in the in the presence of a range of MDL
73811 concentrations (10–150 nM MDL 73811) and cells were
counted after 3 d to determine the EC50. For Western analysis
cultures of blood form T. brucei wild-type cells were split into fresh
media 3 h before dosing with inhibitors. Drug (25 or 75 nM),
cycloheximide (50 mg/ml) or both were then added and samples
were collected at the indicated time points. The ability of this
concentration of cycloheximide to inhibit protein synthesis in T.
brucei has previously been established [23,33,43].
Preparation of AdoMetDC RNAi constructs and cell lines
The techniques for manipulating gene expression in T. brucei by
RNAi have been well established [44]. The pLEW100 and
pJM326 vectors [45] were used to generate the AdoMetDC RNAi
plasmid. A 620 base pair portion of the T. brucei AdoMetDC gene
(starting at the 78
th coding nucleotide) was amplified by PCR
(primers in Table S5) from genomic DNA isolated from T. brucei
427 cells and cloned into the pJM326 vector in the forward
direction and into the pLew100 vector in the reverse direction.
The AdoMetDC fragment fused to the stuffer region was excised
from pJM326 with HindIII and XbaI and inserted into the
modified pLew100 vector. The resulting plasmid contains two
copies of the AdoMetDC gene fragment in opposite orientation
separated by the stuffer DNA sequence (Figure S1A). The
production of stemloop RNA (with double stranded RNA
targeting the AdoMetDC message) is driven from the Tet
inducible procyclin promoter.
Log phase T. brucei 90-13 bloodstream form cells were
transfected with the linearized AdoMetDC stemloop RNAi vector
(80 mg), and phleomycin resistant cells containing the construct
integrated into the rRNA locus were selected as previously
described [11]. Clonal lines were generated by limiting dilution.
Synthesis of double stranded RNA (RNAi) targeting the
AdoMetDC message in a stemloop structure was induced by Tet
(1 mg/ml), which was added fresh every 24 h.
Preparation of prozyme cKO constructs and cell lines
The prozyme conditional knockout line was generated using
previously described methods [46,47]. Identical 300 bp segments of
the prozyme 59 and 39 UTRs (corresponding to nucleotide 2321 to
21 and 1023 to 1348, respectively where base 1 represents the ATG
start and base 978 the TGA stop codons in the protein coding region)
were cloned into the pLEW13 and pLEW90 vectors. The pLEW100
vector was altered by liberating the phleomycin resistance cassette
with DraIII and BssHII and replacing it with the blasticidin resistance
gene from pcDNA6V5His (Invitrogen). The resulting small open
reading frame prior to the blasticidin coding region was removed by
site directed mutagenesis. The resulting vector (pLEW300) was used
to generate the Tet inducible expression plasmid containing Flag-
tagged prozyme, using the tagged gene isolated from the previously
described pT7-FLAG1-prozyme vector [20]. The primers used to
generate the constructs are provided in Table S5, and the construct
diagrams are in Figure S1B.
Log phase T. brucei 427 bloodsteam form cells were transfected
with the Amaxa nucleofector as described [48] to introduce in
successive steps: 1) the pLew13-prozyme SKO-N vector (which
contains coding sequence for T7 polymerase and the G418
resistance cassette inside the prozyme 59 and 39 UTRs) integrated
into the prozyme locus; 2) the pLew300-Flag prozyme construct
(which contains coding sequence for a FLAG tagged prozyme and
the blasticidin resistance cassette) targeted to the rDNA spacer
region; and, 3) pLew90-prozyme SKO-H vector (which contains
coding sequence for the tet repressor and the hygromycin
resistance cassette inside the prozyme 59 and 39 UTRs) integrated
into the second prozyme locus. Clonal lines were generated by
limiting dilution. Prozyme expression was maintained in these
lines by the addition of Tet (1 mg/ml).
Preparation of genomic DNA and Southern blot analysis
Southern blot analysis was used to confirm the genotypes of cKO
cell lines. Genomic DNA (10 mg) was isolated from cells using
standard methods, digested with BanI, separated on a 1% agarose
gel and transferred to a positively charged membrane (Ambion
Bright Star) by vacuum in 106 SSC. The membrane was
crosslinked by UV, prehybridized in Ambion UltraHyb solution
and then hybridized with probe overnight. Blots were washed (0.16
SSC and 0.1% SDS) and visualized with a FLA 5000 phosphoi-
mager. Radiolabeled [
32P]dATP probes were prepared using the
Strip-EZ PCR kit (Ambion) from genomic DNA. The primers used
for generation of the probe by PCR are provided in Table S5. The
probe for the endogenous locus was a 600 bp region starting at
891 bp upstream of the prozyme ATG start site. The probe for the
coding region included nucleotides 78 to 678 of the prozyme gene.
Western blot analysis
Cells (,10
8) were harvested by centrifugation (3,000 rpm),
washed twice in cold phosphate-buffered saline (PBS, pH=7.4),
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5 mM 2-mercaptoethanol, 2 mM phenylmethylsulfonyl fluoride,
1 mg/ml leupeptin, 2 mg/ml antipain, 10 mg/ml benzamidine,
1 mg/ml pepstatin, 1 mg/ml chymostatin), and lysed by three
successive freeze/thaw cycles. The lysate was clarified by
centrifugation (13,200 rpm for 5 minutes) and protein concentra-
tion was determined colormetrically [49].
Protein (20 mg/lane) was separated by 12% SDS/PAGE and
transferred to a polyvinylidene difluoride (PVDF) membrane
(Hybond-P, Amersham). Membranes were blocked in 5% non-fat
milk in Tris-buffered saline (TBS: 20 mM Tris?HCl, 137 mM NaCl,
pH 7.6). Primary and secondary antibody incubations were carried
out in 5% milk TBS-T (TBS plus 0.1% (v/v) Tween-20). Rabbit
polyclonal antibody against T. brucei prozyme was generated (by
Proteintech Group, Inc, Chicago, IL) to recombinant His6-prozyme
purified as described [20] and was used at 4,000-fold dilution. All
other antibodies have been previously described [8,11,12,20] and
were used at the following dilutions: T. brucei AdoMetDC (2,500-fold
dilution), ODC (10,000-fold dilution), L. donovani SpdSyn (1000-fold
dilution),T. brucei TrypSyn (1,000-fold dilution) and T. cruzi TrypRed
(1000-fold dilution). Mouse anti-FLAG M2 antibody (Sigma)(1,000-
fold dilution), horseradish peroxidase-(HRP) linked donkey anti-
rabbit or anti-mouse IgG secondary antibodies (Amersham Biosci-
ences) were used at 10,000 fold dilution. Antigen recognition was
visualized using the ECL chemiluminescent HRP substrate reagents
(Amersham), followed by detection on film. For the AdoMetDC
RNAi cells (Figure 2), separate gels were prepared for each antibody
and the full molecular weight range was transferred to membrane
and probed. This strategy allowed any potential modifications of the
proteins to be detected, and none were observed. Thus only the
appropriate molecular weight range for the probed protein is
displayed in Figure 1. For the prozyme cKO cells (Figure 3) parallel
gels were loaded and transferred, but each membrane was sectioned
into three strips by molecular weight to allow for probing of three
antibodies from one gel. Western analysis was repeated in biological
triplicates and representative experimental sets are displayed
(Figures 2B and 3B).
Quantitative Western analysis
Samples were prepared as described above, parallel gels were
loaded, and each gel was cut into three sections to allow for
probing of multiple antibodies. Each gel was probed for tubulin as
a control. mRNA from these samples was also collected and used
for quantitative northern blot analysis (see below). Primary
antibody raised against AdoMetDC was used at a 500-fold
dilution, tubulin was used at 50,000-fold dilution, and all other
antibodies were used at a 1000-fold dilution in 5% milk-TBS-T.
Alexa-Fluor 647 goat anti-rabbit IgG, Alexa-Fluor 647 goat anti-
mouse IgG or Alexa-Fluor 546 goat anti-mouse IgG (Invitrogen)
secondary antibodies were used at a 500-fold (for AdoMetDC blot)
or 1,000-fold (all other antibodies) in 5% BSA (bovine serum
albumin) TBS-T. Fluorescent signals were measured on a
Typhoon 8610 (Molecular Dynamics,with lex=633 and
lem=670 or lex=532 and lem=580). The bands were quantified
by ImageQuant 5.2 software (Molecular Dynamics). Density from
each antibody was normalized by tubulin density, and each
experimental condition was normalized to control samples.
Quantification of intracellular polyamine and thiol pools
Intracellular polyamine content was analyzed by conjugation to
the fluorescent AccQ-tag reagent (6-aminoquinolyl-n-hydroxysuc-
cinimidyl in acetonitrile, Waters) followed by separation on a
Waters AccQtag (3.96150 mm) column using a Beckman System
Gold HPLC with a Ranin Dynamax Fluorescence detector.
HPLC buffers and gradients have been previously described [50].
The reduced intracellular thiols were quantitated as described
[11,26] by labeling with monobromobimane and separation on a
Phenomonex Nucleosil C18 column (3064.6 mm).
Enzymatic assays of AdoMetDC and ODC activity in cell
lysates
AdoMetDC and ODC activity in cell lysates were determined as
previously described [20,50]. Lysates (40 mg) were incubated with
14C-AdoMet (Amersham; 40 mM) 6 recombinant prozyme
(1 mM) for assay of AdoMetDC or with 1-
14C-ornithine
(Amersham; 80 mM) for assay of ODC. Reactions were allowed
to proceed for 30 minutes at 37uC before quenching with HCl.
Liberated
14CO2 was trapped by barium hydroxide soaked filter
paper and measured by scintillation counting.
Northern analysis
Northern blot analysis was facilitated by the NorthernMax kit
(Ambion). Briefly, mRNA was isolated from trypanosome cells (at
least 1610
8 ) using the micro polyA purist kit (Ambion) and
separated by denaturing 1% agarose gel electrophoresis (1 mg/
lane). The mRNA was transferred to a positively charged nylon
membrane (BrightStar-Plus, Ambion) and cross-linked. Radiola-
beled [
32P]dATP probes were prepared using the Strip-EZ PCR
kit (Ambion) with genomic or plasmid DNA serving as the
template. Data displayed represents a single membrane that was
stripped and reprobed for each of the displayed genes. Signals
were either developed on film, or with a phosphorimager screen.
For quantitation, the signal from the phosphorimager screen
(Molecular Dynamics) was measured on the Typhoon 8610
scanner (Molecular Dynamics, using the 633 nm laser), and
quantified my ImageQuant 5.2 software (Molecular Dynamics).
Gene accession numbers
Gene accession numbers have been taken from http://www.
genedb.org/ and are as follows: AdoMetDC, Tb927.6.4460/
Tb927.6.4410; prozyme, Tb927.6.4470; ODC, Tb11.01.5300;
Spd Syn, Tb09.v1.0380; Tryp Syn, Tb927.2.4370 and Tryp Red,
Tb10.406.0520.
Supporting Information
Figure S1 RNAi and cKO vector diagrams. (A) Vector used to
generate the AdoMetDC stem-loop RNAi construct. (B) Vectors
used to create the prozyme conditional knockout line. Vectors
were inserted into blood form parasites in three steps, starting with
vector 1. Vector construction and trypanosome transfection are
described in the Materials and Methods section.
Found at: doi:10.1371/journal.ppat.1000183.s001 (1.99 MB TIF)
Figure S2 AdoMetDC RNAi cells can be rescued up to four
days after RNAi induction. Spermidine was added to AdoMetDC
RNAi cultures at the time of Tet addition, or two four or six days
post induction, and growth of the cells was monitored.
Found at: doi:10.1371/journal.ppat.1000183.s002 (17.94 MB
TIF)
Figure S3 Tet treatment of blood form T. brucei control cells
does not lead to prozyme or ODC induction. Untransfected 90-13
and 427 bloodstream form cells were cultured in the presence and
absence of Tet for four days.
Found at: doi:10.1371/journal.ppat.1000183.s003 (4.73 MB TIF)
Figure S4 Southern blot confirmation of prozyme cKO.
Genomic DNA was harvested from parental 427, single knockout
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K.O. vector 3), the precursor SKO-N-FP (integrated K.O. vector
1 and exogenous FLAG-prozyme vector 2) and the prozyme cKO
(integrated K.O. vector 1, integrated K.O vector 3 and exogenous
FLAG-prozyme vector 2) cell lines. The genomic DNA was
digested with Ban1 and probed with a region of the 59UTR
(indicated with the blue line) that is present in the endogenous
locus and in each knockout vector (1 and 3, see Figure S1B). Locus
representation is not to scale.
Found at: doi:10.1371/journal.ppat.1000183.s004 (11.70 MB
TIF)
Figure S5 mRNA and protein levels in AdoMetDC RNAi
prozyme cKO cells. Northern blot analysis of mRNA from
AdoMetDC RNAi (A) or prozyme cKO (B) and Western analysis
of prozyme cKO (C) cells in the conditions described in Figures 2
and 3. For Northern analysis, data for each set represent the results
from a single gel that was stripped and reprobed for each gene.
Found at: doi:10.1371/journal.ppat.1000183.s005 (5.95 MB TIF)
Table S1 Metabolite Analysis of AdoMetDC RNAi cells.
Found at: doi:10.1371/journal.ppat.1000183.s006 (0.04 MB
DOC)
Table S2 Metabolite Analysis of prozyme cKO cells.
Found at: doi:10.1371/journal.ppat.1000183.s007 (0.04 MB
DOC)
Table S3 Quantification of protein and mRNA levels. (A)
Normalized ratio of protein to tubulin. AdoMetDC RNAi and 90-
13 parental cells were normalized to the uninduced controls grown
in the same condition. MDL 73811 treated cells were normalized
to the average of untreated 427 controls collected at the identical
time point (24 hours). (B) Normalized ratio of mRNA to tubulin.
Data were analyzed as in (A). (C) Normalized ratios of protein to
mRNA. Ratios of the values for protein/tubulin to mRNA/
tubulin are displayed.
Found at: doi:10.1371/journal.ppat.1000183.s008 (0.06 MB
DOC)
Table S4 Protein Induction: Fold change over controls.
AdoMetDC RNAi (n=3) and Prozyme cKO samples (n=2) were
analyzed by quantitative Western as described in the manuscript.
Reported error represents the standard error of the mean. Tet was
added (AdoMetDC RNAi) or removed (prozyme cKO) on day (D)
zero, samples were collected on D2–D6.
Found at: doi:10.1371/journal.ppat.1000183.s009 (0.03 MB
DOC)
Table S5 Oligonucleotide primers.
Found at: doi:10.1371/journal.ppat.1000183.s010 (0.03 MB
DOC)
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